PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.00
Bid: 121.00
Ask: 125.00
Change: 0.00 (0.00%)
Spread: 4.00 (3.306%)
Open: 123.00
High: 123.00
Low: 123.00
Prev. Close: 123.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

5 Jul 2022 07:00

RNS Number : 2718R
Transense Technologies PLC
05 July 2022
 

Transense Technologies plc

("Transense" or the "Company")

 

Year End Trading Update

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, is pleased to provide a trading update for the financial year ended 30 June 2022 based on unaudited management information.

Highlights

· Results for the year in line with market expectations

· Strong royalty and sales revenue growth

· Progress in product and business development across all divisions

· Cash balanced maintained, despite spending circa £0.30m on a share buyback programme - and with the next quarterly royalty payment of not less than £0.43m due in July

· Resilient business model leads to Board confidence in growth prospects

Revenue, EBITDA & Cash

Revenue for the year has increased by almost 50% to around £2.6m, which is line with market expectations. Adjusted EBITDA* is also expected to be in line with market expectations, and net earnings may exceed market expectations as a consequence of an increased tax credit arising from extending the recognition of deferred tax assets arising from prior years' losses.

Net cash balances at 30 June 2022 amounted to £1.05m (FY21: £1.04m). Trading was cash generative and the Company invested approximately £0.30m in the share buyback programme announced in February 2022. Royalties for the final quarter of the financial year, receivable at the end of July 2022, are expected to be not less than £0.43m, further strengthening the available cash position of the Company.

iTrack Royalties

The underlying royalty income for the financial year from iTrack increased by more than 75% compared with the prior year, reaching US$2m. Royalty income is denominated in US dollars, which has strengthened against Sterling during the year to a level slightly more favourable than the exchange prevailing at the outset of the licence in June 2020. The run rate of royalty income now exceeds £1.85m per annum at current exchange rates, representing an almost threefold increase since inception of the deal. 

Surface Acoustic Wave (SAW)

Revenues were above those of the prior year, primarily due to the sale of torque management systems for motor sport applications and technical support on pre-production projects, including for the GE T901 engine programme. In addition, the Company began to realise income from claims under the Technology Developer Accelerator Programme ("TDAP") grant announced in May 2022, which could in total amount to £0.13m by the end of FY23.

Business development activities have been expanded and continue to generate positive responses. The feedback obtained affirms potential demand for SAW technology across a broad range of applications, including torque and temperature measurement to improve the control and efficiency of electric motor drive units. This in turn has led the Company to commit additional engineering resource, with key appointments including the new Technical Director announced recently. Costs attributable to the SAW business have been contained within budgets set out in the Company's internal business plan and are also in line with market expectations.

Translogik

Translogik tyre probe revenues continue to deliver strong growth with an increase of more than 15% over the prior year. Due to careful management and close co-operation with key suppliers, the well publicised shortages of electronic components has not had any material impact on product availability, and margins have been protected, partly as a consequence of a high proportion of sales arising outside the U.K. and denominated in US dollars and Euros.

The new modular TLGX range is now well established and has been adopted by a number of leading global tyre original equipment manufacturers (OEMs) as the hardware choice to complement their fleet tyre management solutions. As previously reported, the original TL-G1 probe is being phased out and will shortly be entirely replaced by the TLGX range. 

Not all Tyre Management Systems are operated directly by these OEMs. We are increasingly engaging with both software and hardware companies who have a very broad customer base ranging from OEMs to logistics operations, and this has opened up further new exciting opportunities for future growth.

Outlook

The directors are mindful that global economic conditions are likely to become even more challenging in coming months, however, they consider that the Company's business model provides considerable resilience. The momentum that has built up in royalty income now generates sufficient net income to comfortably cover fixed overheads, and Translogik revenue generated in a business-to-business setting is expected to be more reliable than mainstream consumer markets. Furthermore, the directors continue to believe that controlled investment in SAW technology, supported by customer contributions and grant income, offers opportunities to deliver significant levels of commercial revenue in future. Accordingly, the Board is optimistic about growth prospects despite the gathering economic headwinds.

Final audited results for the year ended 30 June 2022 and a more detailed trading update are expected to be released around the end of September 2022.

*Adjusted EBITDA refers to net earnings before interest, taxation, depreciation and amortisation adjusted for the cost of share based payments.

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales & Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.

 

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

 

For further information please contact transense@walbrookpr.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSUNRUOUBRAR
Date   Source Headline
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR
31st Mar 20235:00 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSGrant of share options to Director and employees
20th Mar 20238:49 amRNSTransaction in Own Shares & TVR
20th Mar 20237:00 amRNSTransaction in Own Shares & TVR
13th Mar 20232:49 pmRNSTransaction in Own Shares & TVR
13th Mar 20237:00 amRNSDirectorate and Management Changes
22nd Feb 202310:52 amRNSDirector/PDMR Shareholding - acquisition of shares
22nd Feb 20237:00 amRNSInterim Results & Investor Presentation
7th Feb 20237:00 amRNSNotice of Results & Investor Presentation
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 20226:22 pmRNSDirector/PDMR Shareholding
7th Dec 20222:10 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSTransaction in Own Shares & TVR
1st Dec 202212:03 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
30th Nov 20225:00 pmRNSTotal Voting Rights
14th Nov 20222:51 pmRNSTransaction in Own Shares & TVR
31st Oct 20225:00 pmRNSTotal Voting Rights
24th Oct 20227:00 amRNSPosting of Annual Report & Notice of AGM
17th Oct 20227:00 amRNSTransaction in Own Shares & TVR
4th Oct 20221:44 pmRNSHolding(s) in Company
27th Sep 202211:05 amRNSSecond Price Monitoring Extn
27th Sep 202211:00 amRNSPrice Monitoring Extension
27th Sep 20227:01 amRNSShare Repurchase Programme
27th Sep 20227:00 amRNSFinal Results & Investor Presentation
13th Sep 20227:00 amRNSMoU with Meggitt SA for SAW in aerospace sector
12th Sep 20227:00 amRNSNotice of Results, Investor Pres, AGM & Site visit
5th Jul 20227:00 amRNSYear End Trading Update
4th Jul 20227:00 amRNSSAW update - Appointment of Technical Director
21st Jun 202211:21 amRNSDirector/PDMR shareholding – acquisition of shares
31st May 20225:00 pmRNSTotal Voting Rights
27th May 20227:00 amRNSTransaction in own shares & TVR
26th May 20223:57 pmRNSHolding(s) in Company
24th May 20227:15 amRNSTransaction in own shares & TVR
19th May 20227:00 amRNSTransaction in Own Shares & TVR
17th May 20227:00 amRNSTRT wins place on TDAP & £135k Grant
16th May 20227:00 amRNSTransaction in Own Shares & TVR
11th May 20227:00 amRNSSAW Update
9th May 20227:00 amRNSTransaction in own shares & TVR
3rd May 20227:00 amRNSTransaction in own shares & TVR
26th Apr 20228:54 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
2nd Mar 20225:15 pmRNSHolding(s) in Company
28th Feb 20227:00 amRNSDirector/PDMR - acquisition of shares
22nd Feb 20227:02 amRNSGrant of share options to employees
22nd Feb 20227:01 amRNSShare Repurchase Programme
22nd Feb 20227:00 amRNSInterim Results & Investor Presentation
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.